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ABSTRACT
Heterotrigona itama (Family: Apidae, Tribe: Meliponini, Genus: Trigona) is one of the stingless bee in Meliponiculture in
Malaysia. H. itama honey is reported to be a good reservoir for novel lactic acid bacteria (LAB) with probiotic properties. In
this study, five Lactobacillus brevis strains (strain Ibr-42, strain 37901, strain ATCC 367, strain NJ42 and strain KLDS)
were previously isolated and identified from H. itama honey obtained from local stingless beekeepers in the coastal areas in
Kelantan and Terengganu, were evaluated for antibiotic resistance, antibacterial activity, resistance to low pH, tolerance to
bile salts and haemolytic activity. The results indicated that all five strains of L. brevis were susceptible to chloramphenicol,
ampicillin, erythromycin, and tetramycin, but resistant to kanamycin. In terms of antagonistic activity among L. brevis, it was
found antagonistic activity was minimum. For antibacterial activities of these strains against selected foodborne pathogenic
bacteria by well diffusion method, L. brevis strain NJ42 exhibited the highest inhibition (24 mm) against Pseudomonas
aeruginosa ATCC 15442. All Lactobacillus strains from H. itama honey were able to survive in pH 2 and 0.3% (w/v) bile
salts concentration that mimic the conditions in the gastrointestinal system. The inability of L. brevis strains to exhibit β-
haemolytic activity showing that haemolysis is not the virulence factor for these strains. These findings proved the isolated L.
brevis in H. itama honey could be used as potential probiotic, envisaging its potential as one of functional foods for food
industry.
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INTRODUCTION
Lactic acid bacteria (LAB) are regarded as a major
group of probiotic bacteria which are non-
pathogenic, acid tolerance, bile tolerance and
produce antimicrobial substances (Mojgani et al.,
2015). They are found to be an important reservoir
within humans, insects and animals that confer
important microorganisms for food industries
(Vásquez et al., 2012). Besides, few reports claim
that they also can improve nutritional, organoleptic
and shelf-life characteristics in food products as well
as the safety of food products. (Yang et al., 2012;
Parvez et al., 2006; MacFarlane and Cummings,
2002).
Most probiotic bacteria belong to the genera
Lactobacillus and Bifidobacterium (Prasad et al.,
1998). Probiotics can be classified as “friendly”
microorganism that live in human colon and
when administered in adequate amounts, these
probiotics could confer health benefits on human
(Saarela et al., 2000). Probiotics have received great
attention due to the ongoing trend of vegetarianism
and meeting the demands of lactose intolerant
individuals (Vasudha & Mishra, 2013), inhibit
pathogens in the human intestinal tract, and lower
the risk of gastro-intestinal diseases (Cross, 2002).
Probiotics also have been reported to have anti-
mutagenic, anti-carcinogenic, hypocholesterolemic
and anti-hypertensive effects. The term “probiotics”
microorganism can be applied when they can survive
and resist any adverse factors in the gastrointestinal
tract like stomach acidity and bile salt in the
duodenum when they pass through it (Iñiguez et al.,
2008). From the medical perspective, consumption
of an adequate amount of live cells of certain
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probiotic Lactobacilli strains is believed to promote
several beneficial physiological effects on human
such as maintaining and balancing the healthy
intestinal microbiota as well as reducing the risk of
intestinal infection (Gardiner et al., 2002; Tannock,
2004). The good probiotics organisms have several
criteria to be beneficial to human health such as
high acid tolerance to condition of digestive tract,
production of antibacterial factors, improvement in
the microbial balance and resistance to heat
treatment (Gomes et al., 2009). Up till now, reports
on the probiotic characteristics from LAB isolated
from Heterogona itama is scarce.
Recently, several strains of LABs were isolated
from honey that possessed antibacterial activity
against both Gram-negative and Gram-positive
pathogenic bacteria (Lee et al., 2008; Aween et al.,
2012; Ibarguren et al., 2010; Mohd Hasali et al.,
2015) and fungi (Bulgasem et al., 2016, Bulgasem
et al., 2017). Interest in LAB from stingless bee
honey has increased as limited studies have reported
on their potential as natural food preservative for
extending shelf life. To the best our knowledge, no
study has yet investigated the effect of probiotic
Lactobacillus isolated from H. itama honey as most
of studies focused on health benefits from Tualang
and Manuka honey (Roowi et al., 2012). Therefore,
the purpose of this study is to identify probiotic
characteristics of five Lactobacillus brevis isolated
from H. itama honey according to their antibacterial
activity, antibiotic resistance, antagonistic study,
low pH resistance, bile tolerance test and haemolytic
activity.
MATERIALS AND METHODS
Probiotics strain of Lactobacillus brevis strains
Five L. brevis strains were obtained from study
done by Mohd Hasali et al. (2015). Originally, these
strains were previously isolated from H. itama honey
from various local honey beekeeper in Kelantan and
Terengganu, located at the East Coast of Peninsular
Malaysia. Before use, L. brevis strains were
subcultured onto agar plate of de Man, Rogosa and
Sharpe (MRS) (Merck, Germany). The cultures were
maintained on slant agar supplemented with 20%
glycerol and kept in the freezer at 4°C and -20°C.
Susceptibility of Lactobacillus brevis against
antibiotics
The strains isolated from H. itama honey were
screened for their antibiotic susceptibility by disk
diffusion method using antibiotic disc. The strains
were grown in MRS broth incubated at 37°C for
18 h. The culture suspensions were swabbed onto
MRS agar plates. Antibiotic discs (Oxoid) consisted
of chloramphenicol (30 µg), ampicillin (10 µg),
erythromycin (15 µg), tetramycin (30 µg), and
kanamycin (30 µg) were placed on MRS agar plates
and incubated at 37°C for 48 h. The inhibition zone
surrounds the antibiotic disk was measured using
a caliper. The assay was performed in triplicate.
Antagonistic activity of L. brevis against other
L. brevis strain using overlay method
The Lactobacillus strains were tested for
antagonistic activity against each other in order to
evaluate the ability of each strain of L. brevis to
inhibit other L. brevis strain. This is very important
in the development of multi starter cultures for
food products. The fresh 24 h cultures of indicator
organism was spotted onto MRS agar plates (first
layer) and incubated for 48 h in CO2 incubator. After
incubation, the fresh molten MRS agar was poured
and over-layered on the top of the first layer with
the producer strain. The culture plates were placed
in CO2 incubator under anaerobic condition. The
ability of producer organism to inhibit the indicator
organism was measured via inhibition zone
surrounding the indicator strain colonies (El Soda
et al., 2003).
Antibacterial activity of LAB isolates against food
borne pathogens
Five pathogenic bacteria (Bacillus cereus
ATCC 11778, Escherichia coli ATCC 11775,
Staphylococcus aureus ATCC 25923, Salmonella
Thyphi (clinical strain from local hospital) and
Pseudomonas aeruginosa ATCC 15442) were
cultured in Mueller-Hinton broth (Merck, Germany)
at 37°C for 18 h and swabbed onto Mueller-Hinton
agar (Merck, Germany) using sterile cotton swab.
The 24 h cultures of LAB were sub-cultured into
MRS broth and incubated for 24 h in CO2 incubator.
Then, the cell-free supernatant was obtained from
centrifugation of the isolated LAB at 12 000 rpm
for 10 min at -4°C. The plate agar containing the
pathogen was punched in to make agar well (5 mm
of diameter) using a sterile stainless steel borer. The
agar wells were filled with 70 µl of each L. brevis
cell-free supernatant with the concentration of 100
µg/ml per well and the culture plates were incubated
at 30°C overnight. Commercial antibiotic discs
consisted of chloramphenicol (30 µg), ampicillin (10
µg), erythromycin (15 µg), tetramycin (30 µg), and
kanamycin (30 µg) were used as positive control.
The antimicrobial activity was expressed as the
diameter of the inhibition zone (mm) around the
well (Boyanova et al., 2005). Zones of inhibition
more than 10 mm were regarded as positive
(Georgieva et al., 2015).
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Resistance of L. brevis strains to low pH
The resistance of L. brevis strains to low pH
were evaluated based on the ability of this micro-
organism to survive at pH 2 according to the method
described by Thirabunyanon et al. (2009). One ml
from each overnight pure strains was mixed with
9 ml of MRS broth that had already adjusted to pH
2 and pH 7.2 (control) and incubated at 37°C for
3 h incubation period. The viable population of
L. brevis strains (log10 CFU/ml) were determined
using serial dilution method by spreading on MRS
agar and placed in CO2 incubator at 37°C for 48 h.
The experiment was performed in triplicates and
calculated in form of bacterial cell counts (log10
CFU/ml).
Tolerance of L. brevis strains to Bile Salts
The method described by Thirabunyanon et
al. (2009) was used to determine the tolerance of
Lactobacillus strains to bile salts condition. One ml
from each overnight pure strain was inoculated in
9 ml of MRS broth supplemented with 0.3% of bile
salts (treatment culture) and MRS broth only
(control culture) and incubated for 4 h of incubation
period. The viable strains (log10 CFU/ml) were
determined using serial dilution method by
spreading on MRS agar and placed in CO2 incubator
at 37°C for 48 h. The experiment was performed in
triplicates and the survivor of bacterial cell counts
were determined as log10 CFU/ml.
The haemolytic activities
The haemolytic activity of L. brevis strains was
determined according to Maragkoudakis et al.
(2009). All strains were separately grown in MRS
broth at 37°C for 24 h. Then, the single colony of
each strain was streaked onto Columbia agar base
(Oxoid, UK) plates incorporated with 5% (v/v) sheep
blood. The plates were incubated anaerobically at
37°C for 48 h. Then, the clear zones and the colour
of haemolysis around the growth colonies were
observed. The experiment was performed in
triplicates. The plates were observed for signs of
β-haemolysis (clear zones around colonies),
α-haemolysis (green-hued zones around colonies)
or γ-haemolysis (no zones around colonies).
RESULTS AND DISCUSSION
Susceptibility of L. brevis strains against
antibiotics
The results obtained for antibiotic resistance of
the five L. brevis strains isolated from H. itama
honey is shown in Table 1. The results indicated
that all strains of L. brevis were susceptible to
chloramphenicol, ampicillin, erythromycin and
tetramycin but resistant to kanamycin. Results
showed that L. brevis NJ42 was found to be the
most susceptible compared to other L. brevis strains
towards erythromycin and chloramphenicol with
inhibition zone of 30.0 ± 0.0 mm and 29.00±0.0 mm
as shown in Figure 1, respectively. These result also
was accordance to Mourad and Nour-Eddine, (2006)
which found that most strains of Lactobacillus sp.
were susceptible to most of antibiotics that belonged
to the major classes of antibiotics used in human
clinical therapy. Resistance against kanamycin had
been observed more frequently among Lactobacillus
sp. (Zhou et al., 2005). These result also similar to
the study done by Argyri et al. (2013) which
reported that the majority of LAB isolates including
Leuconostoc strains, L. plantarum strains, L.
pentosus strains, L. paracasei subs. paracasei strains
and L. rhamnosus GG were characterized to be
resistant to kanamycin. As L. brevis strains only
resistant to kanamycin and susceptible to most of
antibiotics, it is suggested that L. brevis is a good
potential as probiotic for food industry.
Antagonistic activity of L. brevis with other L.
brevis strains
The L. brevis strains were also tested for
antagonistic activity against each other. The ability
of producer strain of L. brevis to inhibit indicator
strain of L. brevis was observed and summarized in
Table 1. Susceptibility of L. brevis strains against antibiotics determined by well diffusion method
Diameter of inhibition zone (mm)*
Antibiotics L. brevis L. brevis L. brevis L. brevis L. brevis
strain lbr-42 strain 37901 ATTC 367 strain NJ42 strain KLDS
Ampicillin 26.3 ± 0.3 23.3 ± 0.3 24.8 ± 0.3 30.8 ± 0.3 24.3 ± 0.3
Erythromycin 23.4 ± 0.5 23.0 ± 0.0 24.8 ± 0.3 30.0 ± 0.0 24.3 ± 0.3
Chloramphenicol 24.0 ± 0.0 25.2 ± 0.2 27.3 ± 0.3 29.0 ± 0.0 29.2 ± 0.2
Tetracycline 25.2 ± 0.2 17.0 ± 0.0 19.3 ± 0.3 15.9 ± 0.1 19.8 ± 0.3
Kanamycin No inhibition No inhibition No inhibition No inhibition No inhibition
Control (distilled water) No inhibition No inhibition No inhibition No inhibition No inhibition
*Each result was tabulated from the mean of three independent experiments.
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Fig. 1. MRS plates showing inhibition zone of Lb. brevis strain NJ42 against
erythromycin (A) and chloramphenicol (B).
Table 2. Antagonistic test of L. brevis strains isolated from H. itama honey against other L. brevis as measured by inhibition
zone
Diameter of clear zone (mm)*
L. brevis L. brevis L. brevis L. brevis L. brevis L. brevis
strain lbr-42 strain 37901 ATTC 367 strain NJ42 strain KLDS
L. brevis strain lbr-42 2.8±0.28 3.85±0.21 2.9±0.14 3.9±0.14
L. brevis strain 37901 2.9±0.14 3.9±0.14 3.1±0.14 3.95±0.07
L. brevis ATCC 367 2.8±0.28 2.9±0.14 3.2±0.28 3.9±0.21
L. brevis strain NJ42 2.85±0.21 2.8±0.28 3.75±0.35 3.85±0.21
L. brevis strain KLDS 2.85±0.21 2.85±0.21 3.8±0.28 3.0±0.0
*Each result was tabulated from the mean of three independent experiments.
Table 2. Although the inhibition zones were small,
ranging from 2.8 mm to 3.95 mm, the results
confirms that each Lb. brevis can inhibit other L.
brevis. This characteristic confirms that all L. brevis
strains were able to produce bacteriocin, which was
active against the lactic acid bacteria itself (El Soda
et al., 2003). As the inhibition against other LAB
was small, this characteristic is important in the
development of food products that require multiple
starter cultures, in order to reduce the inhibition
against each other.
Antibacterial activity of L. brevis strains against
food-borne pathogens
The antibacterial activity of L. brevis strains
against foodborne pathogens (B. cereus, S. typhi,
P. aeruginosa, E. coli and S. aureus) is shown in
Table 3. Five strains of L. brevis strains exhibit
inhibition zone ranging from 11 mm to 24 mm
against tested foodborne pathogenic bacteria. The
highest inhibition was found to be L. brevis strain
NJ42 against P. aeruginosa with 24 mm as shown
in Figure 2 compared to commercial antibiotics
(kanamycin, chloramphenicol, tetracycline and
erythromycin) with inhibition zones of 19.5 mm,
15.0 mm, 13.0 mm and 10.0 mm, respectively. For
inhibition of B. cereus, L. brevis strain KLDS and
NJ42 showed the lowest inhibition with 11.3 mm,
whereas commercial antibiotics showed greater
inhibition than all L. brevis strains against B. cereus.
Previous study by Mohd Hasali et al. (2015)
reported that L. brevis exhibited a good antibacterial
activity against S. epidermis, P. aeruginosa and
L. monocytogenes with inhibition zones of 32 mm,
16 mm and 18 mm, respectively.
In the present study, P. aeruginosa was found
to be resistant to ampicillin, which is classified as
broad spectrum anti-pseudomonal antibiotics.
Pseudomonas infection can be treated with a
combination of an anti-pseudomonal beta-lactam
and aminoglycoside. P. aeruginosa resistance
towards antibiotics was reported by Akpaka et al.
(2002) who found P. aeruginosa to be the second
most common isolate among patients with over 30%
of the isolates being resistant to the standard anti-
pseudomonal antibiotics. Interestingly, L. brevis
strain NJ42 showed greater inhibition against
P. aeruginosa than available commercial antibiotics
(kanamycin, chloramphenicol, tetracycline and
erythromycin).
LAB are known as natural antibacterial agents
that have ability to produce various metabolites
such as bacteriocins, hydrogen peroxide and organic
acid (Lawalata et al., 2011). The production of
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Table 3. Antibacterial activity of isolated Lb. brevis from H. itama honey against pathogenic bacteria
Zone of inhibition (mm)
Reference cultures
Bacillus cereus Salmonella Pseudomonas Escherichia Staphylococcusof ATCC Bacteria
ATCC 11778 typhi aeruginosa coli aureusATCC 15442 ATCC 11775 ATCC 25923
L. brevis strain lbr-42 12.3 ± 1.1 15.00 ± 0.0 17.0 ± 1.7 15.7 ± 1.1 15.0 ± 1.0
L. brevis strain 37901 12.3 ± 2.0 12.67 ± 0.5 16.7 ± 0.5 18.7 ± 0.5 14.0 ± 0.0
L. brevis ATCC 367 13.7 ± 0.5 13.00 ± 1.7 17.67±0.5 18.3 ± 0.5 12.3 ± 0.5
L. brevis strain NJ42 11.3 ± 0.5 14.33 ± 0.5 24.00±0.0 19.3 ± 0.5 13.0 ± 0.0
L. brevis strain KLDS 11.3 ± 1.5 16.33 ± 0.5 17.33±0.5 19.3 ± 0.5 12.3 ± 0.5
Ampicillin 13.5 ± 0.7 33.0 ± 0.0 No inhibition 18.0 ± 0.0 38.5 ± 0.7
Erythromycin 34 ± 0.0 24.0 ± 0.0 10.0 ± 0.0 11.0 ± 0.0 27.0 ± 0.0
Chloramphenicol 27.0 ± 0.0 34.0 ± 0.0 15±0.0 32.0 ± 0.0 23.0 ± 0.0
Tetracycline 35.5 ± 0.7 32.0 ± 0.0 13±0.0 34.5 ± 0.7 37.0 ± 0.0
Kanamycin 25.0 ± 0.0 24.0 ± 0.0 19.5±0.7 24.5 ± 0.7 24.0 ± 0.0
Control (distilled water) No inhibition No inhibition No inhibition No inhibition No inhibition
*Each result was tabulated from the mean of three independent experiments.
Fig. 2. Inhibition zone of antibiotic resistant of L. brevis strain NJ42 against P. aeruginosa, E. coli and S. typhi.
antibacterial compounds is the most important
functional properties used to characterize good
probiotics (FAO & WHO, 2006). These results
showed that L. brevis strains exhibit antibacterial
properties that can be used as natural preservative,
especially in dairy food products.
Resistance of L. brevis strains to low pH
Survival of Lactobacillus strains to low pH
condition is one of the important criteria for
probiotics strains (Cakir, 2003). Before reaching the
small intestinal tract, the microorganisms  must pass
through the highly acidic stomach conditions where
the pH can be as low as 1 to 2 in order to exert their
optimal beneficial probiotic effects in the human
host (Dunne et al., 2001). The results of tolerance
to acidic pH is shown in Figure 3. All L. brevis
strains were able to survive in pH 2 during 3 h of
incubation, which represented time taken during
the digestion of food in stomach. The result was
calculated based on viable cell count (CFU/mL) that
L. brevis strains were able to survive in pH 2 and
maintain the bacterial population between 5-6 log10
CFU/ml during 3 h incubation. The viability of
Lactobacillus strains in pH 2 decreased slightly
(about 2 to 3 log10 reduction) compared to control
group of MRS agar without acidic treatment  (pH 7)
but the survival rate was more than 50%, which
was considered as intrinsically tolerant to gastric
transit site (Ashraf & Smith, 2016). Our finding was
supported by Argyri et al. (2013), who reported that
nine strains of L. plantarum, L. pentosus and L.
paracasei subsp. paracasei showed very high
resistance to low pH with final populations
exceeding 8 log10 CFU/ml whereas another 12
strains showed high resistance to low pH with final
populations were within 6-8 log10 CFU/ml during 3
h incubation.
Resistance of L. brevis strains to high bile salts
One of the important characteristic of probiotic
is the ability of microorganism to withstand high
bile salts concentration that mimic the human
digestive system. This study screened five L. brevis
110 PROBIOTIC CHARACTERISATION OF ISOLATED Lactobacillus brevis STRAINS FROM Heterotrigona itama HONEY
strains to tolerate high bile salt condition (approxi-
mately 0.3% (w/v) concentration of bile salt) as
suggested by Mourad and Nour-Eddine (2006). As
displayed in Figure 4, all L. brevis strains were
highly resistant to 0.3% of bile salt environment
during 4 h incubation period, with growth above
log10 7 (CFU/ml). Gilliland et al. (1984) reported
that survival rate of Lactobacillus strains towards
bile salts differed depending on the sources of the
strains. The resistance of bile salts also reported by
Abriouel et al. (2012) who reported that all the LAB
isolated from fermented olive were able to grow and
survive in high bile salt concentration.
The haemolytic activities
Five strains of L. brevis were tested on their
ability to induce haemolysis in vitro when grown
on the sheep blood agar. Non-haemolytic activity
is considered as a safety prerequisite for a probiotic
to be use in food products. Haemolysis can be
defined as a known virulence factor among patho-
genic microorganism. This test is important to
indicate that L. brevis did not have haemolytic
activity, therefore lack of this virulence factor. The
result indicated that all L. brevis strains did not
exhibited β-haemolytic activity when grown in
blood agar contained 5% of sheep blood. Only L.
Fig. 3. Resistance of L. brevis strains to low pH after 3 h incubation (Error bars indicate
standard deviation from three replications).
Fig. 4. Resistance of L. brevis strains to bile salts (3% ox-bile) after 4 h exposure (Error bars
indicate standard deviation from three replications).
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brevis strain lbr-42 exhibited α-haemolytic (partial
haemolysis) while the others were γ-haemolytic,
which can be classified as non-haemolysis strains.
Our results were supported by Maragkoudakis et
al. (2010) who reported that food containing
Lactobacillus strains was rarely to have bacteria that
possesses haemolysis activity.
CONCLUSION
Five L. brevis strains isolated from H. itama honey
were resistant to kanamycin and had good anti-
bacterial activities against food-borne pathogens.
These strains could be considered as appropriate
probiotic candidates due to their resistance against
low pH (pH 2) and 0.3% bile salts concentration as
well as did not exhibited β-haemolysis activity.
They also could be used as adjunct cultures to
improve the quality and nutritional value of dairy
products.
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